AngioDynamics (ANGO) Tops Q1 EPS by 1c, Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $78.7 million versus the consensus estimate of $77.69 million.

GUIDANCE:

AngioDynamics sees FY2024 EPS of ($0.28)-($0.34), versus the consensus of ($0.32). AngioDynamics sees FY2024 revenue of $328-333 million, versus the consensus of $328.6 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• NVE Corporation names new CEO and expands board to seven members
• Pfizer lung cancer drug misses survival goal in Phase 3 trial